Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients

R Venegas-Rodriguez, R Santana-Sanchez, R Peña-Ruiz, M Bequet-Romero, M Hernandez-Cedeño, B Santiesteban-Licea, A Garcia, PR Aroche, D Oliva-Perez, LM Ortega-Gonzalez, J E Baldomero, LR Cruz, G Guillén, G Martinez-Donato, MC Dominguez-Horta, for the CIGB-258 Study Group
doi: https://doi.org/10.1101/2020.05.27.20110601
R Venegas-Rodriguez
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Santana-Sanchez
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Peña-Ruiz
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Bequet-Romero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Hernandez-Cedeño
2CIGB-258 Research and Development Group, Laboratory of Autoimmunity, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Santiesteban-Licea
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Garcia
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PR Aroche
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Oliva-Perez
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LM Ortega-Gonzalez
3Pedro Kourí Hospital. Autopista Novia del Mediodía km 6, La Lisa, Ciudad de la Habana. Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J E Baldomero
2CIGB-258 Research and Development Group, Laboratory of Autoimmunity, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LR Cruz
1Central Military Hospital “Dr. Luis Díaz Soto”. Habana del Este, La Habana, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Guillén
2CIGB-258 Research and Development Group, Laboratory of Autoimmunity, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Martinez-Donato
2CIGB-258 Research and Development Group, Laboratory of Autoimmunity, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MC Dominguez-Horta
2CIGB-258 Research and Development Group, Laboratory of Autoimmunity, Biomedical Research Department, Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31 b/158 and 190, Cubanacán, Playa, PO Box 6162, Havana 11300, Cuba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: MCmcarmen.dominguez@cigb.edu.cu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

This study characterizes the first clinical application of CIGB-258 in COVID-19 patients. CIGB-258 is an immunoregulatory peptide, derived from the cellular heat shock protein 60 (HSP60). Sixteen patients with COVID-19 in serious (31%) or critical (69%) conditions were included in this study. All critically ill patients recovered from the respiratory distress condition. Two of these patients had a fatal outcome due to nosocomial infections.The five seriously ill patients considerably improved. C-reactive protein (CRP) and interleukin-6 (IL-6) levels significantly decreased during treatment. CIGB-258 seems to be an effective and safe treatment option in COVID-19 patients under cytokine storm.

TRIAL REGISTRATION: RPCEC00000313

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

https://rpcec.sld.cu/ensayos/RPCEC00000313-Sp

Clinical Protocols

http://infomed.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-COVID-19

Funding Statement

Study sponsorship was provided by CIGB and Ministry of Public Health of Cuba.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

http://www.cecmed.cu/

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request

https://www.cigb.edu.cu/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 02, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
R Venegas-Rodriguez, R Santana-Sanchez, R Peña-Ruiz, M Bequet-Romero, M Hernandez-Cedeño, B Santiesteban-Licea, A Garcia, PR Aroche, D Oliva-Perez, LM Ortega-Gonzalez, J E Baldomero, LR Cruz, G Guillén, G Martinez-Donato, MC Dominguez-Horta, for the CIGB-258 Study Group
medRxiv 2020.05.27.20110601; doi: https://doi.org/10.1101/2020.05.27.20110601
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
R Venegas-Rodriguez, R Santana-Sanchez, R Peña-Ruiz, M Bequet-Romero, M Hernandez-Cedeño, B Santiesteban-Licea, A Garcia, PR Aroche, D Oliva-Perez, LM Ortega-Gonzalez, J E Baldomero, LR Cruz, G Guillén, G Martinez-Donato, MC Dominguez-Horta, for the CIGB-258 Study Group
medRxiv 2020.05.27.20110601; doi: https://doi.org/10.1101/2020.05.27.20110601

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)